Ilene R. Baylinson's most recent trade in Maximus Inc. was a trade of 156 Dividend Equivalent Rights done . Disclosure was reported to the exchange on May 31, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Maximus Inc. | Ilene R. Baylinson | General Mgr - Health & Human | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2025 | 156 | 38,071 | - | - | Dividend Equivalent Rights | |
Maximus Inc. | Ilene R. Baylinson | General Mgr - Health & Human | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 173 | 37,914 | - | - | Dividend Equivalent Rights | |
Maximus Inc. | Ilene R. Baylinson | General Mgr - Health & Human | Sale of securities on an exchange or to another person at price $ 68.14 per share. | 19 Feb 2025 | 14,500 | 2,511 (0%) | 0% | 68.1 | 988,030 | Common Stock |
Maximus Inc. | Ilene Baylinson R. | General Mgr - Health & Human | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Dec 2024 | 5,172 | 19,603 (0%) | 0% | 0 | Common Stock | |
Maximus Inc. | Baylinson Ilene R. | General Mgr - Health & Human | Payment of exercise price or tax liability using portion of securities received from the company at price $ 74.16 per share. | 02 Dec 2024 | 2,592 | 17,011 (0%) | 0% | 74.2 | 192,223 | Common Stock |
Maximus Inc. | Ilene Baylinson R. | General Mgr - Health & Human | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Nov 2024 | 92 | 23,054 | - | - | Dividend Equivalent Rights | |
Maximus Inc. | Ilene Baylinson R. | General Mgr - Health & Human | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Nov 2024 | 8,168 | 8,168 | - | - | Restricted Stock Units | |
Maximus Inc. | Ilene R. Baylinson | General Mgr - Health & Human | Payment of exercise price or tax liability using portion of securities received from the company at price $ 93.16 per share. | 30 Sep 2024 | 4,924 | 14,429 (0%) | 0% | 93.2 | 458,720 | Common Stock |
Maximus Inc. | Ilene R. Baylinson | General Mgr - Health & Human | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Aug 2024 | 105 | 32,600 | - | - | Dividend Equivalent Rights | |
Maximus Inc. | Ilene R. Baylinson | General Mgr - Health & Human | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2024 | 112 | 32,494 | - | - | Dividend Equivalent Rights | |
Maximus Inc. | Ilene R. Baylinson | General Mgr - Health & Human | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Feb 2024 | 115 | 32,381 | - | - | Dividend Equivalent Rights | |
Maximus Inc. | Baylinson R. Ilene | General Mgr - Health & Human | Sale of securities on an exchange or to another person at price $ 85.57 per share. | 12 Dec 2023 | 10,043 | 5,001 (0%) | 0% | 85.6 | 859,359 | Common Stock |
Maximus Inc. | Ilene Baylinson R. | General Mgr - Health & Human | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Nov 2023 | 32 | 9,010 | - | - | Dividend Equivalent Rights | |
Maximus Inc. | Baylinson Ilene R. | General Mgr - Health & Human | Sale of securities on an exchange or to another person at price $ 83.50 per share. | 30 Nov 2023 | 12 | 9,717 (0%) | 0% | 83.5 | 1,002 | Common Stock |
Maximus Inc. | Ilene R. Baylinson | General Manager - Health & Hum | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Nov 2023 | 7,331 | 7,331 | - | - | Restricted Stock Units | |
Maximus Inc. | Ilene R. Baylinson | General Manager - Health & Hum | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Nov 2023 | 5,349 | 12,388 (0%) | 0% | 0 | Common Stock | |
Maximus Inc. | Ilene R. Baylinson | General Manager - Health & Hum | Payment of exercise price or tax liability using portion of securities received from the company at price $ 82.31 per share. | 17 Nov 2023 | 2,681 | 9,707 (0%) | 0% | 82.3 | 220,673 | Common Stock |
Maximus Inc. | Ilene R. Baylinson | General Mgr - Health & Human | Sale of securities on an exchange or to another person at price $ 74.68 per share. | 29 Sep 2023 | 7,073 | 17,083 (0%) | 0% | 74.7 | 528,212 | Common Stock |
Maximus Inc. | Ilene R. Baylinson | General Mgr - Health & Human | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Aug 2023 | 140 | 40,751 | - | - | Dividend Equivalent Rights | |
Maximus Inc. | Ilene R. Baylinson | General Mgr - Health & Human | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2023 | 139 | 40,610 | - | - | Dividend Equivalent Rights | |
Maximus Inc. | Ilene R. Baylinson | General Mgr - Health & Human | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2023 | 137 | 40,470 | - | - | Dividend Equivalent Rights | |
Maximus Inc. | Ilene R. Baylinson | General Mgr - Health & Human | Sale of securities on an exchange or to another person at price $ 82.74 per share. | 10 Feb 2023 | 9,550 | 10,044 (0%) | 0% | 82.7 | 790,167 | Common Stock |
Maximus Inc. | Ilene R. Baylinson | General Mgr - Health & Human | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Nov 2022 | 123 | 31,125 | - | - | Dividend Equivalent Rights | |
Maximus Inc. | Ilene R. Baylinson | General Mgr - Health & Human | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Nov 2022 | 5,666 | 5,666 | - | - | Common Stock | |
Maximus Inc. | Ilene R. Baylinson | Group General Manager | Sale of securities on an exchange or to another person at price $ 57.87 per share. | 30 Sep 2022 | 5,783 | 19,594 (0%) | 0% | 57.9 | 334,662 | Common Stock |
Maximus Inc. | Ilene R. Baylinson | Group General Manager | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Aug 2022 | 213 | 46,378 | - | - | Dividend Equivalent Rights | |
Maximus Inc. | Ilene R. Baylinson | Group General Manager | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2022 | 198 | 46,164 | - | - | Dividend Equivalent Rights | |
Maximus Inc. | Ilene R. Baylinson | Group General Manager | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2022 | 162 | 45,966 | - | - | Dividend Equivalent Rights | |
Maximus Inc. | Ilene R. Baylinson | Group General Manager | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Nov 2021 | 124 | 33,565 | - | - | Dividend Equivalent Rights | |
Maximus Inc. | Ilene R. Baylinson | Group General Manager | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Nov 2021 | 5,535 | 5,535 | - | - | Common Stock | |
Maximus Inc. | Ilene R. Baylinson | Group General Manager | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Aug 2021 | 161 | 50,239 | - | - | Dividend Equivalent Rights | |
Maximus Inc. | Ilene R. Baylinson | Group General Manager | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2021 | 150 | 50,078 | - | - | Dividend Equivalent Rights | |
Maximus Inc. | Ilene R. Baylinson | Group General Manager | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2021 | 171 | 49,927 | - | - | Dividend Equivalent Rights | |
Maximus Inc. | Ilene R. Baylinson | Group General Manager | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Nov 2020 | 139 | 42,841 | - | - | Dividend Equivalent Rights | |
Maximus Inc. | Ilene R. Baylinson | Group General Manager | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Nov 2020 | 6,915 | 6,915 | - | - | Common Stock | |
Maximus Inc. | Ilene R. Baylinson | Group General Manager | Sale of securities on an exchange or to another person at price $ 68.41 per share. | 30 Sep 2020 | 8,852 | 19,672 (0%) | 0% | 68.4 | 605,565 | Common Stock |
Maximus Inc. | Ilene R. Baylinson | Group General Manager | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Aug 2020 | 194 | 54,109 | - | - | Dividend Equivalent Rights |